HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 61.80
-0.30 (-0.48%)
May 8, 2026, 12:52 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.85 billion as of May 8, 2026. Its market cap has decreased by -20.82% in one year.
Market Cap
2.85B
Enterprise Value
2.38B
Revenue
293.23M
Ranking
n/a
PE Ratio
25.51
Stock Price
61.80
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.85B, a decrease of -31.42%. That is a compound annual growth rate of -13.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.85B | -1.59% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.21B |
| Shine-On BioMedical | 3.18B |
| Genovate Biotechnology | 3.09B |
| TWi Biotechnology | 3.09B |
| Intech Biopharm | 3.05B |
| BRIM Biotechnology | 2.98B |
| Chunghwa Chemical Synthesis & Biotech | 2.98B |
| Apex Biotechnology | 2.83B |